ANAVEX LIFE SCIENCES CORP. Pre-Tax Income
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Pre-Tax Income of -$46.38 million for the 12-month period ending 2025-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-09-30 was -$11.74M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-06-30 was -$12.28M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2024-03-31 was -$10.44M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2023-12-31 was -$8.54M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$46.38M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$43.00M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$47.50M.
- ANAVEX LIFE SCIENCES CORP. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$47.62M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$46.38M 10-K/A · filed 2026-08-28 | |||||||
| 2024-09-30 | -$11.74M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$24.02M derived: sum of 2 quarters · filed 2026-08-28 | -$34.47M derived: sum of 3 quarters · filed 2026-08-28 | -$43.00M 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | -$12.28M 10-Q · filed 2024-08-06 | -$22.72M derived: sum of 2 quarters · filed 2024-08-06 | -$31.26M 10-Q · filed 2024-08-06 | -$41.47M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | -$10.44M 10-Q · filed 2024-05-09 | -$18.98M 10-Q · filed 2024-05-09 | -$29.19M derived: sum of 3 quarters · filed 2026-08-28 | -$40.43M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | -$8.54M 10-Q · filed 2024-02-07 | -$18.75M derived: sum of 2 quarters · filed 2026-08-28 | -$29.99M derived: sum of 3 quarters · filed 2026-08-28 | -$43.04M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | -$10.21M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$21.45M derived: sum of 2 quarters · filed 2026-08-28 | -$34.51M derived: sum of 3 quarters · filed 2026-08-28 | -$47.50M 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | -$11.24M 10-Q · filed 2024-08-06 | -$11.24M 10-Q · filed 2023-08-08 | -$24.30M derived: sum of 2 quarters · filed 2024-08-06 | -$37.29M 10-Q · filed 2024-08-06 | -$37.29M 10-Q · filed 2023-08-08 | -$51.37M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | -$13.06M 10-Q · filed 2024-05-09 | -$13.06M 10-Q · filed 2023-05-09 | -$26.05M 10-Q · filed 2024-05-09 | -$26.05M 10-Q · filed 2023-05-09 | -$40.13M derived: sum of 3 quarters · filed 2024-05-09 | -$52.41M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$12.99M 10-Q · filed 2024-02-07 | -$12.99M 10-Q · filed 2023-02-07 | -$27.07M derived: sum of 2 quarters · filed 2024-02-07 | -$39.35M derived: sum of 3 quarters · filed 2024-02-07 | -$49.76M derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | -$14.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | -$26.36M derived: sum of 2 quarters · filed 2023-11-27 | -$36.77M derived: sum of 3 quarters · filed 2023-11-27 | -$47.62M 10-K · filed 2023-11-27 | -$47.62M 10-K · filed 2022-11-28 | |||
| 2022-06-30 | -$12.28M 10-Q · filed 2023-08-08 | -$22.69M derived: sum of 2 quarters · filed 2023-08-08 | -$33.54M 10-Q · filed 2023-08-08 | -$45.12M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2022-03-31 | -$10.41M 10-Q · filed 2023-05-09 | -$21.26M 10-Q · filed 2023-05-09 | -$32.84M derived: sum of 3 quarters · filed 2023-11-27 | -$42.98M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-12-31 | -$10.85M 10-Q · filed 2023-02-07 | -$22.43M derived: sum of 2 quarters · filed 2023-11-27 | -$32.57M derived: sum of 3 quarters · filed 2023-11-27 | -$40.70M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-09-30 | -$11.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | -$21.72M derived: sum of 2 quarters · filed 2023-11-27 | -$29.85M derived: sum of 3 quarters · filed 2023-11-27 | -$37.64M 10-K · filed 2023-11-27 | -$37.64M 10-K · filed 2021-11-24 | |||
| 2021-06-30 | -$10.14M 10-Q · filed 2022-08-09 | -$18.27M derived: sum of 2 quarters · filed 2022-08-09 | -$26.07M 10-Q · filed 2022-08-09 | -$32.02M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | -$8.13M 10-Q · filed 2022-05-10 | -$15.92M 10-Q · filed 2022-05-10 | -$21.88M derived: sum of 3 quarters · filed 2022-11-28 | -$28.36M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | -$7.80M 10-Q · filed 2022-02-09 | -$13.75M derived: sum of 2 quarters · filed 2022-11-28 | -$20.23M derived: sum of 3 quarters · filed 2022-11-28 | -$27.47M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | -$5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$12.44M derived: sum of 2 quarters · filed 2022-11-28 | -$19.68M derived: sum of 3 quarters · filed 2022-11-28 | -$26.26M 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | -$6.48M 10-Q · filed 2021-08-12 | -$13.72M derived: sum of 2 quarters · filed 2021-08-12 | -$20.30M 10-Q · filed 2021-08-12 | -$25.90M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$7.24M 10-Q · filed 2021-05-13 | -$13.82M 10-Q · filed 2021-05-13 | -$19.42M derived: sum of 3 quarters · filed 2021-05-13 | -$25.92M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$6.58M 10-Q · filed 2021-02-16 | -$12.18M derived: sum of 2 quarters · filed 2021-02-16 | -$18.69M derived: sum of 3 quarters · filed 2021-02-16 | -$25.88M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | -$12.10M derived: sum of 2 quarters · filed 2020-12-28 | -$19.30M derived: sum of 3 quarters · filed 2020-12-28 | -$26.21M 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | -$6.50M 10-Q · filed 2020-08-06 | -$7.05M 10-Q · filed 2019-08-07 | -$13.70M derived: sum of 2 quarters · filed 2020-08-06 | -$20.61M 10-Q · filed 2020-08-06 | -$22.34M 10-Q · filed 2019-08-07 | -$26.17M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | -$7.20M 10-Q · filed 2020-05-07 | -$7.96M 10-Q · filed 2019-05-09 | -$14.11M 10-Q · filed 2020-05-07 | -$15.28M 10-Q · filed 2019-05-09 | -$19.67M derived: sum of 3 quarters · filed 2020-05-07 | -$22.52M derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | -$6.91M 10-Q · filed 2020-02-06 | -$7.32M 10-Q · filed 2019-02-07 | -$12.47M derived: sum of 2 quarters · filed 2020-02-06 | -$15.32M derived: sum of 3 quarters · filed 2020-02-06 | -$20.04M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-09-30 | -$5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -$8.41M derived: sum of 2 quarters · filed 2019-12-16 | -$13.13M derived: sum of 3 quarters · filed 2019-12-16 | -$17.18M 10-K · filed 2019-12-16 | -$17.38M 10-K · filed 2018-12-12 | |||
| 2018-06-30 | -$2.85M 10-Q · filed 2019-08-07 | -$7.57M derived: sum of 2 quarters · filed 2019-08-07 | -$11.62M 10-Q · filed 2019-08-07 | -$16.77M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$4.72M 10-Q · filed 2019-05-09 | -$8.77M 10-Q · filed 2019-05-09 | -$13.92M derived: sum of 3 quarters · filed 2019-05-09 | -$17.52M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$4.05M 10-Q · filed 2019-02-07 | -$9.20M derived: sum of 2 quarters · filed 2019-02-07 | -$12.80M derived: sum of 3 quarters · filed 2019-02-07 | -$14.33M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-09-30 | -$5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | -$8.75M derived: sum of 2 quarters · filed 2019-01-25 | -$10.29M derived: sum of 3 quarters · filed 2019-01-25 | -$13.40M 10-K · filed 2019-01-25 | ||||
| 2017-06-30 | -$3.60M 10-Q · filed 2018-08-09 | -$5.14M derived: sum of 2 quarters · filed 2018-08-09 | -$8.26M 10-Q · filed 2018-08-09 | -$14.76M derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2017-03-31 | -$1.54M 10-Q · filed 2018-05-10 | -$4.66M 10-Q · filed 2018-05-10 | -$11.16M derived: sum of 3 quarters · filed 2019-01-25 | -$13.39M derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2016-12-31 | -$3.12M 10-Q · filed 2018-02-07 | -$9.62M derived: sum of 2 quarters · filed 2019-01-25 | -$11.86M derived: sum of 3 quarters · filed 2019-01-25 | -$13.89M derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2016-09-30 | -$6.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | -$8.74M derived: sum of 2 quarters · filed 2019-01-25 | -$10.77M derived: sum of 3 quarters · filed 2019-01-25 | -$14.71M 10-K · filed 2019-01-25 | ||||
| 2016-06-30 | -$2.23M 10-Q · filed 2017-08-07 | -$4.27M derived: sum of 2 quarters · filed 2017-08-07 | -$8.20M 10-Q · filed 2017-08-07 | -$13.56M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2016-03-31 | -$2.03M 10-Q · filed 2017-05-10 | -$5.97M 10-Q · filed 2017-05-10 | -$11.32M derived: sum of 3 quarters · filed 2017-12-11 | -$15.56M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2015-12-31 | -$3.94M 10-Q · filed 2017-02-07 | -$9.29M derived: sum of 2 quarters · filed 2017-12-11 | -$13.53M derived: sum of 3 quarters · filed 2017-12-11 | -$15.26M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2015-09-30 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | -$9.60M derived: sum of 2 quarters · filed 2017-12-11 | -$11.32M derived: sum of 3 quarters · filed 2017-12-11 | -$12.11M 10-K · filed 2017-12-11 | ||||
| 2015-06-30 | -$4.24M 10-Q · filed 2016-08-11 | -$5.97M derived: sum of 2 quarters · filed 2016-08-11 | -$6.75M 10-Q · filed 2016-08-11 | |||||
| 2015-03-31 | -$1.72M 10-Q · filed 2016-05-11 | -$2.51M 10-Q · filed 2016-05-11 | ||||||
| 2014-12-31 | -$786.72K 10-Q · filed 2016-02-08 | |||||||
| 2014-09-30 | -$11.37M 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |